Last reviewed · How we verify

NCT05817123: VAMOS

Validation of the Mutuality Scale in Patients With OSA and Their Partners

Completed Last updated 29 February 2024
What this trial tests

trial testing Questionnaires in Obstructive Sleep Apnea in 50 participants. Completed in 30 September 2022.

Timeline
10 May 2021
Primary endpoint
31 May 2022
30 September 2022

Quick facts

Lead sponsorIstituto Auxologico Italiano
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date10 May 2021
Primary completion31 May 2022
Estimated completion30 September 2022
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituto Auxologico Italiano — full company profile →

Who can join

18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Main objective of this study is to assess the psychometric characteristics of the Mutuality Scale both in patients with Obstructive Sleep Apnea Syndrome (OSAS) and in their partners-The association between the mutuality score in OSAS patients and their adherence to the use of Continuous Positive Airway Pressure (CPAP) therapy will also be investigated. The results of the study may allow a validation of the Mutuality Score as an instrument for measuring mutuality between OSAS patients and their partners.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other Istituto Auxologico Italiano trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05817123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing